New radioactive tracer aims to shine a light on hidden prostate cancer
NCT ID NCT07236112
First seen Nov 19, 2025 · Last updated May 05, 2026 · Updated 17 times
Summary
This early-phase study tests a new radioactive tracer called TRDC002 to see if it can help find prostate cancer that has come back or spread. The tracer attaches to a protein (PSMA) on cancer cells and lights them up on a PET scan. Six adults with recurrent or metastatic prostate cancer will receive two different doses to find the best dose and timing for clear images, while also checking for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Union Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.